UK Ambassador Matthew Gould 311.
(photo credit: UK Embassy in Israel (YouTube))
As funds for medical research in Israel are always inadequate, new UK-Israel
medical research fellowships will provide a shot in the arm.
Embassy in Israel and the British Council recently announced the launching of
the state-of-the-art medical research program. The fellowships form part of the
Britain- Israel Research and Academic Exchange (BIRAX) Partnership, a
multimillion- pound bilateral research program that promotes regenerative
medicine research to find cures for the world’s worst diseases.
academic connections between the UK and Israel and develop advanced therapies,
the BIRAX Regenerative Medicine Initiative will support research visits by UK
and Israel researchers for up to six months to laboratories in both countries.
The program follows seven joint projects that have been awarded up to £400,000
each for research over three years. Up to 30 fellowships will be awarded, each
worth up to £12,600 each.
The fellowship program is an exciting
opportunity for scientists to undertake visits to the UK and Israel to further
their research experience, establish or strengthen research links, learn new
techniques and research methods that are not available in their home
laboratories and facilitate collaboration between the home and host research
groups, the embassy said.
UK Ambassador to Israel Matthew Gould added:
“The launch of this fellowship program represents a major stepping up of
scientific collaboration between Britain and Israel. We’re offering our most
talented young scientists in both countries the chance to work with each other.
The potential for this cooperation is huge – both our countries are scientific
superpowers, with world class laboratories doing cutting-edge
We should be natural partners in science, and this fellowship
program will help us fulfill that potential. ” GENDER DIFFERENCE IN RESEARCH
FRAUD Male scientists are far more likely to commit fraud than females, and such
fraud occurs across the career spectrum, from trainees to senior faculty. The
analysis of professional misconduct was co-led by a researcher at Yeshiva
University’s Albert Einstein College of Medicine in New York and was published
recently in the journal mBio.
“The fact that misconduct occurs across all
stages of career development suggests that attention to ethical aspects of
scientific conduct should not be limited to those in training, as is the current
practice,” said senior Einstein author Dr. Arturo Casadevall.
finding – that males are overrepresented among those committing misconduct –
implies a gender difference we need to better understand in any effort to
promote the integrity of research.”
The team reviewed 228 individual
cases of misconduct reported by the US Office of Research Integrity (ORI) from
1994 through 2012. They found that fraud was involved in 215 (94 percent) of the
228 cases reported by the ORI. Of these, 40% involved trainees, 32% faculty
members and 28% other research personnel (research scientists, technicians,
study coordinators and interviewers).
Overall, 65% of the fraud cases
were committed by males.
The study did not examine why men are more
likely to commit fraud.
One possibility is that misconduct is
“As research has shown, males tend to be risk
takers, more so than females, and to commit fraud entails taking a risk,” said
Casadevall. “It may also be that males are more competitive or that women are
more sensitive to the threat of sanctions. I think the best answer is that we
don’t know. Now that we have documented the problem, we can begin a serious
discussion about what is going on and what can be done about
Casadevall recommended periodic ethics training for scientists at
all levels of academia.
“Right now we target trainees for ethics
training,” he added. “We don’t do anything after they are hired. It might help
if universities required refresher courses in ethics, as they do with courses to
prevent sexual harassment in the workplace.
It won’t stop all misconduct,
but it’s one place to start.”